Press Release August 12, 2018 – Chiome Bioscience Inc. (hereinafter, “Chiome”) announced today that it has executed a Collaborative Development License and Exclusive Option Agreement (hereinafter, “Agreement”) with SemaThera Inc. (Home office: Montreal, Canada;...